Scan.com raises £165m led by Noteus Partners with Aviva
This article covers Scan.com, a healthtech startup that has raised £165m in combined equity and debt in a growth funding round. The funding will accelerate provider onboarding, support M&A and investment in its API and AI routing infrastructure to scale a national imaging network serving providers, insurers, employers and patients.
Scan.com, a healthtech startup, has raised £165 million in combined equity and debt in a growth funding round — £65 million of Series C equity led by Noteus Partners plus £100 million of debt facilities from VerisFi Capital and Atempo Growth — to accelerate provider onboarding, M&A and investment in its API and AI routing infrastructure. The deal underlines the company’s push to turn fragmented medical imaging into a single, searchable national network.
Why it matters
Medical imaging is one of the largest and most fragmented parts of US healthcare. The market is valued at over $100 billion, yet long waits, large price variations and manual booking processes remain common: Scan.com cites that 85% of scans are still booked by fax or phone. That combination creates inefficiencies — scanners sitting idle near oversubscribed centres, variable pricing unrelated to quality, and administrative costs passed to patients.
The funding is intended to scale a national digital layer that matches demand to live capacity and price, automates scheduling and paperwork, and routes reports to sub-specialist radiologists. If successful, that could reduce wait times, lower administrative friction and make pricing more transparent across large employer, insurer and digital health channels.
Inside the product
Scan.com provides a single national API that integrates live and two-way with independent imaging centres’ scheduling systems and electronic medical records. Third parties — digital health providers, employer benefit platforms, third-party administrators, health plans and workers’ compensation systems — connect with a few lines of code rather than building multiple bespoke integrations.
Every referral is matched against live availability, price and subspecialty across the network; scheduling and paperwork are handled automatically. Scan.com says each report is routed using AI to a radiologist who sub-specialises in the relevant area. A team of care guides accompanies patients through the process, and results are typically returned within 48 hours.
Commercial traction data in the announcement shows revenue doubled over the past year to surpass a $165 million annualised run rate, and more than 900,000 patients have accessed care through the network globally. The new debt facilities are earmarked to support M&A and working capital as the company expands provider coverage across the US.
Who are the investors?
The £65 million Series C equity round was led by Noteus Partners, with participation from Aviva, Concord Health Partners, YZR Capital, Oxford Capital and others. Debt facilities totalling £100 million come from VerisFi Capital and Atempo Growth.
Noteus Partners leads the round and frames its investment around the founders’ long-term execution and the company’s data and connectivity assets. Aviva’s participation signals insurer interest in solutions that can manage imaging spend and access. Concord Health Partners is positioned to support businesses that reduce cost and increase access in care delivery.
In the announcement, Nathalie Bruls, General Partner at Noteus Partners, said:
We have known Charlie and Oli for many years, and few teams have strengthened our conviction as consistently over time as they have. Their bold vision and relentless execution have brought Scan.com to a point where years of investment in patient experience, provider connectivity and proprietary data are increasingly compounding, building an advantage that only continues to deepen with scale and AI. Modern healthcare systems need to deliver better outcomes and lower costs. We led this round as we see Scan.com uniquely positioned to power that future, having built the network and intelligence layer for diagnostic imaging.
In the announcement, James Olsen, Managing Partner at Concord Health Partners, said:
Scan.com's ability to improve access to high-quality diagnostic imaging while reducing cost and complexity is directly aligned with Concord's mission to support companies that improve quality, increase access and reduce the cost of care. We look forward to supporting the Scan.com team as they continue to expand their technology-enabled network and improve how imaging is accessed and delivered across the United States.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
In the announcement, Charlie Bullock, Co-founder & CEO at Scan.com, said:
The US runs around 600 million medical imaging scans a year, and there is still no national infrastructure behind them. Labs got that decades ago with Quest Diagnostics and Labcorp. Imaging never did, and that is what we have built. An employer, a health plan or a digital health app can now connect to imaging capacity nationwide through a single API, and their patients get scanned at a quality-checked center in days rather than weeks, at a price they can see before they schedule. This investment is about making that the standard in US healthcare, rather than the exception.
The quote positions Scan.com as attempting to replicate the nationalised lab model in imaging, using connectivity and AI rather than owning scanning assets.
The bigger picture
Scan.com is already the United Kingdom’s largest medical imaging network and expanded into the US in 2023. The combination of equity and debt financing reflects a broader pattern in healthtech where growth capital is paired with structured debt to fund consolidation and technology investment. The deal also highlights continued interest from insurers and specialised health investors in companies that can reduce cost and administrative complexity in clinical pathways.
If Scan.com can sustain accelerated provider onboarding and prove workflow and cost improvements at scale, the model could shift how imaging capacity is allocated across health systems — a recurring theme for healthtech investors looking to tackle entrenched, offline healthcare processes in both the UK and the US.
They've invested in Scan.com
Get to know these healthtech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Noteus Partners( ) | ||||
 Aviva Ventures( ) Aviva focuses on innovation within the financial services sector, emphasizing ve... London  | ||||
 Concord Health Partners( ) | ||||
 YZR Capital( ) YZR is a venture capital firm focused on the European health tech sector, invest... Munich, Germany  | ||||
 Oxford Capital( ) Oxford Capital is a venture capital firm based in Oxford, specialising in early-... London | ||||
 VerisFi Capital( ) | ||||
 Atempo( ) Atempo Growth is a venture capital firm focused on backing European tech compani... London | GeneralistHealthtech | |||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK